WallStreetZenWallStreetZen

NASDAQ: ZNTL
Zentalis Pharmaceuticals Inc Stock Ownership - Who owns Zentalis Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Zentalis Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ingmar BrunsChief Medical Officer2025-02-0620,000$2.28
$45.66kBuy
Mark LacknerChief Scientific Officer2025-02-0314,368$1.71
$24.60kSell
Andrea PaulChief Legal Officer2025-02-0313,230$1.71
$22.65kSell
Vincent VultaggioPAO and Interim PFO2025-02-032,615$1.71
$4.48kSell
Jan SkvarkaDirector2025-01-3160,000$1.72
$103.44kBuy
Julia Marie EastlandCEO President2025-01-3128,500$1.73
$49.33kBuy
Luke Nathaniel WalkerDirector2025-01-3114,200$1.76
$24.96kBuy
Mark LacknerChief Scientific Officer2025-01-024,411$3.12
$13.76kSell
Vincent VultaggioPrincipal Accounting Officer2024-10-041,603$3.18
$5.10kSell
Cam GallagherPresident Interim CFO2024-05-319,597$11.98
$114.97kSell

1 of 2

ZNTL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZNTL insiders and whales buy or sell their stock.

ZNTL Shareholders

What type of owners hold Zentalis Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Matrix Capital Management Company LP19.44%13,959,973$18.01MInsider
Matrix Capital Management Company LP19.44%13,959,973$18.01MInstitution
Eventide Asset Management LLC6.23%4,475,054$5.77MInstitution
Blackrock Inc5.90%4,238,089$5.47MInstitution
Viking Global Investors LP5.49%3,943,284$5.09MInsider
David E. Goel5.32%3,821,739$4.93MInsider
Anthony Y. Sun5.26%3,780,043$4.88MInsider
Vanguard Group Inc4.56%3,271,240$4.22MInstitution
Citadel Advisors LLC4.48%3,216,727$4.15MInstitution
Decheng Capital LLC3.26%2,338,095$3.02MInstitution

1 of 3

ZNTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZNTL67.39%32.61%Net BuyingNet Buying
ALEC61.11%38.89%Net SellingNet Selling
TNXP48.86%51.14%Net SellingNet Selling
CCCC78.11%21.89%Net SellingNet Selling
COYA26.57%12.80%Net Buying
View Top Biotech Stocks

Zentalis Pharmaceuticals Stock Ownership FAQ

Who owns Zentalis Pharmaceuticals?

Zentalis Pharmaceuticals (NASDAQ: ZNTL) is owned by 89.70% institutional shareholders, 43.41% Zentalis Pharmaceuticals insiders, and 0.00% retail investors. Matrix Capital Management Company LP is the largest individual Zentalis Pharmaceuticals shareholder, owning 13.96M shares representing 19.44% of the company. Matrix Capital Management Company LP's Zentalis Pharmaceuticals shares are currently valued at $18.99M.

If you're new to stock investing, here's how to buy Zentalis Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.